Traws Pharma (TRAW)

• Market cap: $18.3M
• 1 day: -2.65%
• 5 days: -6.88%
• 1 month: 38.92%
• 3 months: 66.88%
• 6 months: 77.24%
• Year to date: -70.36%
• 1 year: -49.01%
• 5 years: -97.29%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Employees: 7